Hoerter Steven L. — SEC insider filings
SEC reporting owner CIK 1533451. 36 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 36 filings on record, filed 2020-08-24 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 20,000 shares, $264,984 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 94,675 shares, $1,596,208 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 48.
- Largest priced transaction: sale of 30,045 shares @ $16.00 ($480,720) in Deciphera Pharmaceuticals, Inc., filed 2023-02-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Deciphera Pharmaceuticals, Inc. | President and CEO, Director | 13 | — | 4 legs · 89,782 sh · $1,327,974 | 22 |
| MBX Biosciences, Inc. (MBX) | Chairman, President and CEO, Director | 11 | 1 leg · 20,000 sh · $264,984 | 1 leg · 4,893 sh · $268,234 | 11 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) | Director | 3 | — | — | 6 |
| Oric Pharmaceuticals, Inc. (ORIC) | Director | 6 | — | — | 6 |
| C4 Therapeutics, Inc. (CCCC) | Director | 3 | — | — | 3 |
Insider filings — Hoerter Steven L.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | MBX Biosciences, Inc. (MBX) | Sale (S): 4,893 @ $54.82 | EDGAR |
| 2026-08-04 | 4 | MBX Biosciences, Inc. (MBX) | Grant/award (A): 71,000 @ $0 · Grant/award (A): 331,000 (derivative) @ $0 | EDGAR |
| 2026-06-26 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 62,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | MBX Biosciences, Inc. (MBX) | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | MBX Biosciences, Inc. (MBX) | Grant/award (A): 11,938 @ $0 · Grant/award (A): 74,249 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4/A | MBX Biosciences, Inc. (MBX) | Grant/award (A): 33,751 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4/A | MBX Biosciences, Inc. (MBX) | Grant/award (A): 0 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-11-25 | 4 | MBX Biosciences, Inc. (MBX) | Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2025-11-07 | 4 | MBX Biosciences, Inc. (MBX) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-10-20 | 4 | MBX Biosciences, Inc. (MBX) | Purchase (P): 20,000 @ $13.25 | EDGAR |
| 2025-06-20 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 35,500 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | MBX Biosciences, Inc. (MBX) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2025-04-09 | 4 | MBX Biosciences, Inc. (MBX) | Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-11-21 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/award (A): 25,600 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Deciphera Pharmaceuticals, Inc. | Grant/award (A): 286,075 · Disposition to issuer (D): 286,075 · Code (U): 72,763 · Disposition to issuer (D): 395,735 (derivative) · Disposition to issuer (D): 270,357 (derivative) · Disposition to issuer (D): 415,000 (derivative) · +2 more | EDGAR |
| 2024-02-20 | 4 | Deciphera Pharmaceuticals, Inc. (DCPH) | Grant/award (A): 298,100 (derivative) @ $0 | EDGAR |
| 2023-12-14 | 4 | Deciphera Pharmaceuticals, Inc. (DCPH) | Grant/award (A): 62,500 · Sale (S): 30,664 @ $15.37 | EDGAR |
| 2023-10-31 | 4 | Deciphera Pharmaceuticals, Inc. (DCPH) | Grant/award (A): 62,500 · Sale (S): 21,573 @ $12.02 | EDGAR |
| 2023-06-15 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/award (A): 20,500 (derivative) @ $0 | EDGAR |
| 2023-03-23 | 4 | Deciphera Pharmaceuticals, Inc. (DCPH) | Sale (S): 7,500 @ $15.57 | EDGAR |
| 2023-02-16 | 4 | Deciphera Pharmaceuticals, Inc. (DCPH) | Sale (S): 30,045 @ $16 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2022-06-17 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/award (A): 50,283 (derivative) @ $0 | EDGAR |
| 2022-03-23 | 4 | Deciphera Pharmaceuticals, Inc. (DCPH) | Tax withholding (F): 3,150 @ $9.11 | EDGAR |
| 2022-01-20 | 4 | Deciphera Pharmaceuticals, Inc. (DCPH) | Grant/award (A): 415,000 (derivative) @ $0 | EDGAR |
| 2021-12-17 | 4 | Deciphera Pharmaceuticals, Inc. (DCPH) | Grant/award (A): 270,357 (derivative) @ $0 | EDGAR |
| 2021-08-16 | 4 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/award (A): 33,250 (derivative) @ $0 | EDGAR |
| 2021-07-23 | 4/A | CONSTELLATION PHARMACEUTICALS INC (CNST) | Disposition to issuer (D): 26,342 (derivative) | EDGAR |
| 2021-07-19 | 4 | CONSTELLATION PHARMACEUTICALS INC (CNST) | Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 26,342 (derivative) · Disposition to issuer (D): 13,171 (derivative) | EDGAR |
| 2021-06-04 | 4 | CONSTELLATION PHARMACEUTICALS INC (CNST) | Grant/award (A): 13,171 (derivative) @ $0 | EDGAR |
| 2021-03-22 | 4 | Deciphera Pharmaceuticals, Inc. (DCPH) | Tax withholding (F): 700 @ $42.39 · Tax withholding (F): 2,450 @ $43.19 | EDGAR |
| 2021-02-18 | 4 | Deciphera Pharmaceuticals, Inc. (DCPH) | Grant/award (A): 210,000 (derivative) @ $0 | EDGAR |
| 2021-01-25 | 4 | Deciphera Pharmaceuticals, Inc. (DCPH) | Option exercise (M): 1,078 @ $25.40 · Option exercise (M): 1,078 (derivative) @ $0 | EDGAR |
| 2020-08-24 | 4 | Deciphera Pharmaceuticals, Inc. (DCPH) | Option exercise (M): 187 @ $25.40 · Option exercise (M): 187 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1533451 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs